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                                   INTRODUCTION  
Tuberculosis  is  one of  the oldest  diseases known to affect  human. 
Today  pulmonary  tuberculosis  has  become  the  important  communicable 
disease in the world with one-fifth if the global Tuberculosis incidence is 
from  newly  diagnosed  cases  within  India.  Approximately  two  million 
people acquire tuberculosis yearly. Of this around 45 percent will be active 
tuberculosis.  The  prevalence  of  tuberculosis  in  India  according to  recent 
WHO report is 283 per 1,00,000 population ,with 2.83 percent being MDR-
TB , ie., multi drug resistant tuberculosis. In spite of availability of effective 
treatment the annual deaths due to tuberculosis in India is 3,31,000.
Tuberculosis flourishes where poverty malnutrition overcrowding and 
lack  of  adequate  medical  care  are  seen.  Diabetes  mellitus,  alcoholism, 
malnutrition,  chronic  lung  disease  and  any  debilitating  or 
immunosuppressive  conditions  are  considered  to  enhance  the  chances  of 
contracting this dreaded disease.
TUBERCULOSIS IN DIABETES:
Tuberculosis  is  a  single  infectious  disease  that  involves  multiple 
endocrine organs namely adrenal cortex anterior and posterior pituitary and 
parathyroid gland. It doesn’t directly involve insulin secretion of beta cells 
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of pancreas but worsens the metabolic control in diabetes.
Some  antituberculous  drugs  produce  problems  in  management  of 
diabetes  .On  the  other  hand  Diabetes  mellitus  aggravates  the  existing 
tuberculous infection and also activates silent or dormant tuberculous focus 
in the body.
Vicenna (980- 1027 A.D) is said to have been the first to note the 
frequent association of Diabetes    and tuberculosis.1 It is greatly agreed that 
pulmonary  tuberculosis  develops  early  in  untreated  diabetes  ,  and  once 
present ,progression is rapid unless both the conditions are treated .Wilson 
Fox (1981), found that tuberculosis commonly appeared diabetes has been 
lasted for 1-2 year. 
The link between diabetes mellitus and pulmonary tuberculosis has 
been talked of at various fora, but has never occupied the centrals stages of 
discussion. There is a growing amount of evidence of one disease fuelling 
the other. The interest in diabetes and tuberculosis is mounting rapidly and it 
promises to be an exciting time for researchers and clinician involved in the 
study of dual diseases. 
Also  the  clinical  and radiological  manifestations  of  tuberculosis  is 
varying among diabetes and non diabetes population. There are numerous 
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issues of basic, applied and operational research waiting for solution. It is a 
wake  up  care  for  all  clinicians  and  researchers  to  gear  up  to  meet  the 
challenge of the brewing double trouble. Hence an attempt has been made to 
study the dual issue among native South Indian population to confirm or 
refute the published observation.
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                                                  AIM OF THE STUDY
1.  To screen diabetics  for  pulmonary tuberculosis  and find out  the 
prevalence of tuberculosis   in diabetic patients.
2. To estimate the age groups and sex ratio in diabetic patients with 
tuberculosis.
3. To study and compare clinical symptoms and signs of tuberculosis 
associated with diabetes.
4. To  assess  the  various  patterns  of  radiological  findings  in 
tuberculosis in association with diabetes.
5. To  correlate  the  smoking  habits  with  reference  to  prevalence  of 
tuberculosis in diabetic and non diabetic population.
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                                     REVIEW OF LITERATURE
 DIABETES MELLITUS- TUBERCULOSIS:
  
The link between diabetes mellitus and pulmonary tuberculosis has 
been talked of at various fora but has never occupied the centre – stage of 
discussions. Presently, an epidemic of diabetes is on both in developed and 
developing nations. With the recognition of this explosive, increase in the 
number  of  people  diagnosed  with  diabetes  mellitus  allover  the  world,  a 
whole  new  field  of  issues  related  to  interaction  between  diabetes  and 
pulmonary tuberculosis has been thrown open.
The global figure of people with diabetes is projected to rise from the 
current estimate of 150 million to 220 million in 2010 and 300 million in 
2025  most  cases  will  be  of  type  -2  diabetes,  which  is  characterized  by 
insulin  resistance  and  or  abnormal  insulin  secretion  .people  with  type-2 
diabetes  are  not  dependent  on  exogenous  insulin,  but  may  require  it  for 
control of blood glucose levels if this is not achieved with diet alone or with 
oral hypoglycaemic agents. 
The diabetic epidemic, although apparent across the world, has been 
most pronounced in non-European populations, as evidenced by studies in 
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the native American and Canadian communities, pacific and Indian ocean 
island populations, groups in India and Australian aboriginal communities. 
The potential for increase in the number of cases of diabetes is greatest in 
Asia. Type -2diabetes in children, teenagers,  and adolescents is a serious 
new aspect to the epidemic and is an emerging public health problem of 
significant proportions.
Based on compilation of studies from different parts of the globe, the 
world  heath  organization  has  projected  that  the  maximum  increase  in 
diabetes would occur in India. Considering the large population and the high 
prevalence  of  diabetes  could  be  enormous.  With  an  estimated  23million 
today and the numbers set to increase to 57million by 2025, the increasing 
prevalence  of  diabetics  reflects  the  sedentary  life-style,  excessive  energy 
intake, reduced physical activity and obesity.
Studies conducted in India in the last decade have highlighted that not 
only is the prevalence of type-2 diabetes high, but also that it is increasing 
rapidly in the urban population. Of particular interest are the results of the 
three diabetic surveys conducted in Chennai in 1989, 1995 and 2000. They 
show a rising trend for diabetes mellitus and glucose intolerance. The period 
between 1989 and 1995 show a 40% rise in the prevalence. A nation-wide 
study conducted in six major cities in India in the year 2000 showed that the 
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prevalence of diabetes in urban adults aged more than 20 years was 12.1%. 
Onset of diabetes occurs at younger age in Indians. 
The prevalence of impaired glucose tolerance test, which is a fore-
runner  of  diabetes,  is  also  increasing  especially  among  the  younger 
population. There is also a wide urban-rural difference in the prevalence of 
diabetes  pointing  to  the  major  role  urbanization  may  be  playing  in  the 
causation of the disase.
Patients with diabetes mellitus are also at a higher risk of tuberculosis. 
This has been highlighted by several retrospective and prospective studies. 
In  a  study  in  Mumbai,  tuberculosis  was  found  to  be  the  most  common 
complicating illness  (5.9%) in  a  large cohort  of  over  8000 patients  with 
diabetes mellitus3.In a recent study from the Regional Institute of Medical 
Science, Imphal, the prevalence of pulmonary tuberculosis in diabetics was 
found to be 27% by radiological diagnosis and 6% by sputum positivity4. A 
rising  prevalence  of  tuberculosis  in  diabetes  has  been  seen  with  age. 
Mortality rates in these patients are reported to be several times higher than 
in non-diabetic pulmonary tuberculosis patients. Although the relative risk 
of developing pulmonary tuberculosis and mortality is several times higher 
in  patients  with  diabetes  mellitus  than  in  matched  controls,  the  clinical 
symptoms and pulmonary tuberculosis are believed to be similar in patients 
with  or  without  diabetes  mellitus  .And  so  more  the  bacteriological 
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conversion rates, and relapse rates. However, those with diabetes mellitus 
nay relapse more often with resistant strains. In a recently published study 
from Congo diabetes appeared to have an induction and aggravating effect 
on tuberculosis. Tuberculosis was found to be more frequent in diabetics, 
had more pronounced radiological signs, treatment failures and deaths were 
also more frequent.
Do patients with tuberculosis too have a higher prevalence of diabetes 
mellitus?  There is  not enough evidence to give a definitive answer,  but 
there  are  some  trends.  Studies  conducted  after  the  introduction  of  the 
glucose tolerance test in 1950s,  have shown high prevalence of impaired 
glucose tolerance test in patients with tuberculosis with rates ranging from 2 
to  41`% 6.the  use  of  different  criteria  for  diagnosis  of  diabetes  mellitus 
makes  comparisons  between  the  results  of  the  studies  almost  impossible 
there  have  been reports  of  high  prevalence  rates  of  diabetes  in  cases  of 
pulmonary tuberculosis (4-20%) and rates are higher for impaired glucose 
tolerance test (16-29%) .After anti- tuberculosis therapy, 50% of them had 
normalization of glucose intolerance. Some investigators have reported an 
association  between  severity  of  tuberculosis  and  abnormal  glucose 
tolerance.   However, no association has been found with age, family history 
of tuberculosis, ethnicity or duration of treatment. 
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The cause(s) of increased susceptibility are not yet clearly understood. 
Some believe it to be due to the lowered production of interleukin -1B and 
tumor  necrosis  factor-  a  by  peripheral  blood monocytes  in  patients  with 
tuberculosis and co- existent diabetes mellitus. Or is it the non –enzymatic 
glycosylation of tissue proteins inducing an alteration in connective tissue in 
diabetes mellitus diabetic autonomic neuropathy leading to abnormal basal 
airway tone due to an alteration in vagal pathways and thus cause a reduced 
bronchial reactivity and bronchodilatation is also considered as one of the 
probable causes. 
Irrespective of the triggering mechanism(s), the face remains that an 
epidemic of diabetes mellitus is sweeping the country .the recent prevalence 
data has propelled the estimates for India upwards -32m in 2000and 80m in 
2030. India is also the home to the largest number of tuberculosis patients in 
any one country. And there is a growing amount of evidence of one disease 
fueling  the other.   The  interest  in  diabetes  and tuberculosis  is  mounting 
rapidly and it promises to be an exciting time for researchers and clinicians 
involved in the study of dual diseases. There are numerous issues of basic, 
applied and operational research waiting for solutions.
It is a wake–up call for clinicians and researchers to gear-up to meet 
the challenge of the brewing double trouble.
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DIABETES   &   TUBERCULOSIS: A DANGEROUS LIAISON 
Diabetes  mellitus  is  becoming  a  global  epidemic  and  India,  in 
particular, is noted as hosting a high proportion of this disease burden. There 
are approximately 41 million prevalent cases of DM in India and as per the 
International Diabetes Federation (IDF) ESTIMATES BY 2025 this will rise 
to about 70 million, the largest number for any country1. 
As well  as nationally  predicted rises in DM rates,  regional  studies 
have  also  shown  increasing  rates  of  disease,  with  the  largest  reported 
increases  in  low and  middle  income  countries  occurring  amongst  urban 
population2.surveys conducted in Chennai ,India , in 1989 and subsequently 
in 1995 showed a40 per cent rise in the prevalence of diabetes over this 
period3.  However  India   not  only  faces  the  public  health  difficulties 
associated  with newly increasing rates of chronic  diseases such as DM  ,but 
as with other low and middle income  countries, endures sustained rates of 
infectious diseases (such as TB) which remain to be brought under  control. 
One –fifth   of the global TB incidence is from newly diagnosed cases 
within India; approximately 2 million people acquire TB yearly. Around 45 
per  cent  of  these  incident  cases  will  be  infectious  to  others,  further 
increasing the high TB disease rates4. It is estimated that annually around 
3,31,000 people in India die form TB5.  The recent WHO report indicates 
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that the prevalence of tuberculosis in India is 283 per 100,000 population 
with approximately 2.8 per cent of prevalent cases being problematic multi 
drug resistant  (MDR) TB5.  It  should however be noted that although TB 
rates are high in India, by 2006 directly observed treatment short –course 
(DOTS) was being provided nationally. In India, case detection is estimated 
to have increased from below 20 per cent up to 67 per cent as DOTS was set 
up throughout all 30 districts4. 
Rather  than  just  existing  alongside  each  other  as  diseases  of  high 
burden, TB and DM are thought to be associated with one another. Each 
disease is thought to be able to exacerbate the other and when an individual 
presents with both diseases concomitantly disease outcomes may be poorer. 
Reports on the association between DM and TB are found as far back 
as  1000  A.D.  when  Avicenna  noted  that  “phthisis”,  (a  Greek  term  for 
tuberculosis), often complicated diabetes and that the presence of diabetes 
resulted in an increased risk of developing TB6. 
However,  recently  it  has  gone  unmentioned  in  many  global  TB 
guidelines  and  in  the  most  recent  national  guidelines  has  only  been 
mentioned as something needing more research5,7. If not acknowledged   and 
dealt  with  appropriately,  the  association  could  pose  a  threat   both  to 
successful TB control and DM treatment. 
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Diabetes as a risk factor for TB:
Patients with diabetes mellitus have been found to have a higher than 
average risk of contracting tuberculosis. A study carried out at the regional 
Institute  of  medical  sciences,  Imphal  found the prevalence  of  pulmonary 
tuberculosis  in  people  with  diabetes  to  be  27  per  cent  by  radiological 
diagnosis and six percent by sputum positivity8.
In  a  study  in  Mumbai,  tuberculosis  was  found  to  be  the  most 
commonly occurring concomitant illness in diabetics with 5.9 percent of the 
individuals  in a cohort  of over 8000 being co- morbidly affected9.
A meta – analysis demonstrated that having diabetes was associated 
with  overall  risk  (Relative  Risk)  of  3.11  percent  for  contracting 
tuberculosis10.A systematic  review11 reporting  on  the  association  found  9 
studies in which diabetes was estimated to increase risk of infection from 
1.5 to 7.8 fold11.
Gender seems to have no bearing upon this relationship, however the 
relative risk for  contracting tuberculosis  among individuals  with diabetes 
does vary by age, being highest in younger groups11.
In order to illustrate the potential public health importance of diabetes 
as a risk factor for tuberculosis, Stevenson et al, 11  estimated the population 
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attributable  risk  (PAR),  for  tuberculosis  from  diabetes  in  India.  They 
calculated  that  diabetes  could account  for  approximately  14.8  percent  of 
sputum positive cases12.This calculation highlights the impact the diabetes 
epidemic could have upon TB rates in India, perhaps active case finding 
amongst  people  with  diabetes  will  become  appropriate  in  order  to  help 
control tuberculosis.
TUBERCULOSIS AS A RISK FACTOR FOR DIABETES:
The majority of studies identify and discuss the presence of diabetes 
as  a  risk  factor  for  tuberculosis,  but  could  the  relationship  between 
tuberculosis  and  diabetes  be  bi-directional?   Engel  Bach13 and  Nichols14 
posited  that  not  only  could  having  diabetes  increase  an  individual’s 
likelihood of developing tuberculosis   but that having TB could lead to the 
presentation of diabetes. Studies have also shown both a high prevalence of 
diabetes  and  of  impaired  glucose  tolerance  (IGT),  in  patients  with 
tuberculosis15.  However,  it  is  not  often  known  if  diabetes  or  IGT  were 
present prior to the TB infection as high as a high proportion of people with 
diabetes and especially IGT are unaware of their status.
Some  studies  have  noted  a  normalization  of  glucose  levels  after 
Tuberculosis  treatment  in  individuals  who had developed hyperglycemia. 
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This poses a question as to whether it is the active disease or the treatment 
for it causes these metabolic abnormalities16.
It  is  known that  tuberculosis,  as  with other  infections,  complicates 
diabetes  management,  and  some  of  the  TB  treatment,  regimes  which 
includes isoniazid or rifampicin have hyperglycemic effects.
POSSIBLE CASUAL PATHWAYS FOR THE ASSOCIATIONS:
Diabetes is known to cause immune dysfunction and moderate suppression 
of the immune system 19. Specifically, diabetes has been shown to suppress 
cell  mediated immunity. Diabetes has been associated with a decrease in 
levels of leucocytes and polymorph nuclear neutrophils.
A   reduced T helper  (Th 1)  cytokine  response  level  is  also  seen 
amongst diabetic individuals19,20. This immune dysfunction is detrimental to 
the immune response against tuberculosis. Th 1 cytokines are vital in control 
and  inhibition  of  Mycobacterium  tuberculosis  bacilli.  For  example, 
interferon  gamma,  is  important  for  combating  microbial  infections  and 
both  Interferon-  gamma  and  Tumor  necrosis  factor-  alpha,  activate 
macrophages19,20.   Activated  macrophages  release  active  oxygen  species 
(ROS), and free radicals such as nitric oxide which are essential for control 
of infection such as nitric oxide which are essential for control of infection, 
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including tuberculosis. Not only are macrophages release reactive oxygen 
species (ROS) and free radicals such nitric oxide which are essential for the 
control of infection, including tuberculosis21. Not only are macrophages the 
primary  site  of  infection  but  these  cells  also  instigate  the  main  immune 
response to tuberculosis22.  
Macrophage  function  is  found  to  be  inhibited  in  individuals  with 
diabetes,  with  production  of  ROS,  and  phagocytic  and  chemo  tactic 
functions being impaired. All of these immune processes are important for 
tuberculosis clearance and as such, diminution of these give a very plausible 
pathway  for  the  increased  relative  risk  of  tuberculosis  seen  among 
individuals with diabetes19,20.
Macrophage  function  has  also  been  some  plausible  mechanisms 
highlighted  in  the  literature  through  which  tuberculosis  infection  could 
cause  hyperglycemia  .For  example,  aspects  of  the  inflammatory  immune 
response  to  tuberculosis  infection  could  lead  to  an  increase  in  insulin 
resistance for  a decrease in insulin production resulting in an increase in 
blood glucose22. 
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EFFECTS OF CO-MORBIDITY ON DISEASE OUTCOMES:
As  would  be  anticipated,  given  the  above  considerations,  co-
morbidity with tuberculosis and diabetes is associated with deterioration in 
both  the  conditions.  A  higher  mortality  rate  for  tuberculosis  when 
complicated with diabetes has been reported.(23,24). Co-presentation related 
of  tuberculosis  and diabetes  is  associated  with increased  diabetes  related 
complications  and  poorer  blood glucose  control.  Conversely,  tight  blood 
sugar  control  is  thought  to  reduce  the  risk  of  tuberculosis  infection  in 
individuals with diabetes. Concomitant TB and DM is associated with more 
severe features of TB including increased involvement of lower lung fields, 
and longer periods of smear positivity25,26.
A study carried out in Nijmegen showed that individuals presenting 
with concomitant DM and TB, are more likely to have positive results after 
six  months  of  TB treatment.27.  This  may  be because,  bacterial  clearance 
takes a longer time in diabetic patients  or that  bacterial  load is initially 
higher and thus takes longer to diminish. A study carried out in Texas border 
population found that multi-drug resistant TB (MDR-TB), was associated 
with DM with an odds ratio of 2.127, while other studies show no increased 
association between DM and MDR-TB29,30. 
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Nijland et al28, reported that rifampicin was not absorbed effectively 
in TB-DM patients; this could be due to poor gastrointestinal uptake, or due 
to differences in metabolism, excretion and bodyweight-31.
However in India evaluations of the category I treatment regimen (not 
recommended  for  all  smear  positive  cases)  of  the  Revised  National 
Tuberculosis  Control  Programme  (RNTCP)  have  suggested  that  it  is 
appropriate for people with concomitant diabetes32,33.
It is generally accepted that Tuberculosis is more prevalent among the 
diabetes than non diabetes.  The reported prevalence rate varies. As for as 
back as 600 AD the association of these two diseases as noted by Saruthy; 
Avicenna was reported to have noted this association more than thousand 
years ago.
 
The  relationship  between  diabetes  and  tuberculosis  date  back  to 
Roman times.  Autopsies in the 18th and 19th centuries were happening this 
association. Although the preparude bacillus was not discussed until 1882.
Presently  an  epidemics  of  diabetes  is  on  both  in  developed  and 
developing nations. With the recognition of this explosive increase in the 
number  of  people  diagnosed with  diabetes  mellitus  all  over  the  world  a 
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whole  new  field  of  issues  record  to  inter  action  between  diabetes  and 
Pulmonary Tuberculosis has been thrown open.
The ponal figure of people with diabetes in projected to rise from the 
correct estimate of 150 million 220 million in 2010 and 300 million in 2015 
most cases of diabetes will two type of diabetes, which is charecterised by 
insulin resistance and  / or abnormal insulin secretion.  People with type two 
diabetes  are  not  dependant  on  exogenous  insulin  but  may  require  it  for 
control of blood glucose levels if this was not achieved with diet alone or 
with oral hypoglycemic agents. 
The diabetic epidemic although apparent among the world has been 
most pronounced in Non-European population as evidenced by Smalies in 
the native American and Canadian Communities, Pacific and Indian Ocean 
Island populations, groups in India and Australian Aborigional communities. 
The potential for inverse in number of cases of diabetes is greatest in Asia. 
Type two diabetes  in  children,  adolescents  and  teenagers  is  serious  new 
aspect  to  the epidemic and is  an emerging public  problem of significant 
proportion.
Bases of complication of studies from different parts of Globe  The 
World Health Organisation has projected that  increase in diabetes would 
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occur  in  India.  Considering  the  large  population  and high prevalence  of 
diabetes, the burden if diabetes could be enormous.  With an estimation 23 
million today,  the number set to  increase   to 57 million by 2025, the 
increasing prevalence of diabetes reflects the sedentary life style excessive 
energy intake, reduced physical activity and obesity.  Studies conducted in 
India last decade have high lighted that not only the prevalent of type two 
diabetes but also that it is increasing rapidly in the urban population.   Of 
particular interest are results of three diabetic surveys conducted in Chennai 
in 1989,1995 and 2000. They show a rising trend for diabetes and glucose 
intolerance. The period between 1989 and 1995 shows a 40 per cent rise in 
the prevalence.  
A nationwide studies conducted in six major cities in the year 2000 
showed the prevalence of diabetes in urban adults aged more than 20 years 
was 12.1 per cent.  Onset of diabetes occurs at younger age in Indians.  The 
prevalence  of  impaired  glucose  tolerance  test  which  is  a  fore  runner  of 
diabetes is also increasing, especially among the younger population.  There 
is also a wide urban-rural difference in the prevalence of diabetes pointing to 
the major role in urbanization may be paying in the causation this diseases. 
It  is  generally  accepted  that  in  pulmonary  tuberculosis  is  more 
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prevalent among diabetics than in non-diabetics.  The reported prevalence of 
tuberculosis rate varies.  The increasing TB morbidity among diabetics has 
strongly been substantiated by studies of the incidence of correlation.  These 
statistical  analysis  have  been  made  either  on  DIABETIC  PATIENTS 
material  being  taken  from the  case  histories,  in  the  medical  wards  and 
special diabetic hospitals and in diabetic out patient clinics or on autopsy 
findings and tuberculosis notification.  
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1. Progressive age related changes in pulmonary tuberculosis images and 
effect of diabetes. Perz Guzman et al., Int. J. Tuberc. Lung disease 2001 
May,  5  (5),  455-61.  Atypical  radiological  images  of  pulmonary 
tuberculosis and elderly and diabetics. In diabetics a high frequency of 
lower lung lesions and cavitations are observed in all age groups.
2. Tuberculosis  and diabetes  D.C Lahiri   and P.K.Sen (From  B.C.Roy 
Research Institute , Calcutta) Indian. J. of Tuberculosis. Vol. x, xi, No.2 
1974. The prevalence of diabetes is 6.5% in pulmonary tuberculosis.
3. Pulmonary tuberculosis and diabetes  P.A.Deshmukh   and  T.Shah  Ind. 
J. of  TB.,1984.,31-114.
4. The  incidence  of  tuberculosis  in  diabetes  was  5.6%.  Routine  post 
breakfast  blood  glucose  estimation  should  be  done  in  all  pulmonary 
tuberculosis patients to find out association of tuberculosis.
5. Diabetes mellitus and  pulmonary tuberculosis .S. R. Tripathy et al ., 
Ind. J. TB 1984, 31, 122   the prevalence of   tuberculosis is 4.1 %   of 
known diabetic patients.
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6. Diabetes and Tuberculosis – The brewing double trouble  by Lalit Kunt 
Ind. J. Tub. Vol  50. , No.4. ,Oct 2003. Tuberculosis was found to be 
more frequent in diabetes and more   pronounced. 
7. Diabetes and tuberculosis : a dangerous liaison & no white tiger Indian 
J.  of .TB., Res 130 ,  July 2009 , pp1-4 People with diabetes may be 
important  targets  for  interventions  such  as  active  case  finding  and 
treatment of latent tuberculosis.
22
                                                            MATERIALS AND METHODS  
  
SETTINGS  :         Diabetology department and Tuberculosis clinic.
STUDY DESIGN :        Prospective analytical study.
PLACE :       Govt. Kilpauk Medical College&Hospital, Chennai  
DURATION OF STUDY : October 2008 to June 2009  
MATERIALS :  Five  hundred  cases  of  established  Diabetes  mellitus 
who  attended  the  diabetology  department  were 
screened for prevalence of tuberculosis.
INCLUSION CRITERIA:   [STUDY GROUP]
1. Patients with   Type 2 diabetes mellitus with 
respiratory symptoms
2. Age group 19  to 75 years
3. Both sexes
4. Duration of diabetes was from newly diagnosed to 
maximum 25 years
CONTROL GROUP:   Hundred patients with tuberculosis alone and not 
with Diabetes selected randomly from tuberculosis 
clinic.
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EXCLUSION CRITERIA:
                                1. Patients treated earlier for tuberculosis
                                2. Immunosuppressed states    (i)   HIV positivity
                                                                                 (ii)  Steroid therapy
                                                                                 (iii)  Chronic renal failure
CONSENT  :     Informed  consent  was  obtained  was  obtained  from all 
patients who were included in the study.
ETHICAL CLEARENCE:
Project was approved by the ethical committee Govt. Kilpauk medical 
college.
 
METHODS: 
Five hundred cases of  diabetes  mellitus  patients  were screened for 
tuberculosis based on inclusion criteria and exclusion criteria.  Prevalence 
was found to be 56 cases of   tuberculosis among the five hundred diabetic 
patients.  Hundred  cases  of  patients  with tuberculosis  alone  and without 
diabetes alone were taken as controls. 
All  patients  in  this  study  as  well  as  control  group  underwent  full 
clinical evaluation .Clinical history and physical examination findings were 
recorded  with  particular  attention  to  Age  ,  Sex,  BMI  ,  Symptoms   and 
Clinical features of tuberculosis.
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SYMPTOMS:        Of duration 2 weeks to six months. Cases underwent the 
investigations  for  confirming  the  diagnosis  of 
tuberculosis. 
 
                                1.  Cough with expectoration
                                2.  Fever 
                                3.  Loss of weight 
                                4.  Loss of appetite 
                                5.  Loss of weight
                                6.  Haemoptysis
                                7.  Breathlessness
                                8.  Chest pain
                                9.  Others
PHYSICAL EXAMINATION:    
All  patients  with  established  diabetes  underwent  thorough 
physical examination both General and Systemic examination. 
LAB INVESTIGATIONS:
                       BLOOD
                             1. Total Wbc count
                             2.   Differential count
                             3.   Erythrocyte sedimentation rate
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                             4.   Haemoglobin
                             5.   Blood sugar:     Fasting (overnight) and   Potprandial 
                  
                             6.    Blood Urea
                             7.    Serum Creatinine
                           
                             8.    Fasting Lipid profile 
URINE:
1. Albumin, sugar and deposits.
             
MANTOUX:
                             PPD       RT 23    of    1 Tuberculin unit was used.
CHEST X RAY: 
                   Mass Miniature Radiography   /   Large X Ray
SPUTUM FOR ACID FAST BACILLI:
                              1. Sample A
                              2. Sample B
 
OTHERS:   CT Chest 
X ray chest radiological lesions were analysed by number of zones 
involved,  nature  of  lesions like infiltration,  consolidation,  fibrosis,  cavity 
and consolidation etc.
STASTICAL ANLYSIS:
Datas were entered in a Microsoft Excel computers read   sheet and 
analysed by using WHO epidemiological information package.
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                                                                            SUGGESTIONS
It is worth remembering that early diagnosis of this combination of 
DM and TB is not that easy.
When a combination of DM and TB is diagnosed , the  TB disease is 
already in advance stage  that it  makes management  more difficult  ,and 
clinical outcome is poor.
           From this study the following suggestions were made.
The only way to recognize this dreadful combination is 
1. X ray examination                                          (i)   Once in a year   or 
                                                                            (ii)  with excess weight loss 
                                                           
                                                                            
                   
2.X ray  with Sputum AFB examination            (i)  for patients with   cough 
                                                                                 with expectoration more 
                                                                                than two  weeks
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                    STUDY RESULTS AND DISCUSSION
             The study group comprised of 500 subjects who had established 
diabetes mellitus taking treatment as patients in Dr.Ambedkar institute of 
diabetes, Govt.  Kilpauk Medical College. Out of 500 subjects 56 patients 
[TB  DM]  group  were  found  to  be  suffering  from  also  pulmonary 
tuberculosis. 56 age matched patients suffering from tuberculosis alone and 
non diabetics  selected  randomly  were  compared  with   DIABETIC TB 
GROUP [ DM-TB]  for age wise break up , and   sex   distribution, clinical 
symptoms and  various patterns of radiological lesions and number of zones 
involved.
1.  AGE AND SEX DISTRIBUTION
TO  COMPARE  THE  AGE  GROUP  IN  YEARS,  AND  SEX 
DISTRIBUTION FOR THE STUDY, SUBJECT WITH COMBINATION 
OF DIABETES WITH PULMONARY.
TUBERCULOSIS AGAINST TUBERCULOSIS ALONE
TB-DM GROUP              [ n= 56]  
NON DM-TB GROUP   [ n= 56 ]
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TABLE - 1
 
  
 
DM-TB NON DM- TB 
No. of subjects 56 56
Male 35 43
Female 21 13
Male: Female ratio 1.67 3.31
Male Female
DM-TB 62.5% 37.5%
NON DM- TB 76.8% 23.2%
INFERENCE 
i) Out of 56 cases in our TB-DM, 35 were male and 21 were 
females.
ii) In  out  of  56  NON  DM-TB  population,  there  were  43 
males and 13 females.
iii) Thus sex, male : female ratio  was found to  be 1. 67 in DM-
TB GROUP   and 3..31 for  NON DM-TB  GROUP. This 
shows  a  male  preponderance  in  DM-TB  GROUP,  THAN 
NON DM-TB group
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1. Tripathy et al.,  [1984] found the male: female ratio of 4:1 in patients 
having pulmonary tuberculosis with diabetes.
2. It  is  made  out  that  males  are  more  susceptible  than  females  for 
pulmonary  tuberculosis  associated  with  diabetes.  ICMR 
[Anon  1958]  conducted  a  national  survey  and  presented  its  salient 
findings. 
3. Regarding sex Deshmukh, [1979] has listed a large number of causes 
grouped under occupation. The occupational hazard involved as silicosis 
of lungs involved in hard coal mining, textile industry containing sucking 
thread  of  bobbin,  proximity  to  patients,  socio  economic  level 
characterized by hard work and poor nutrition. This information lands 
support to the present findings, even though studies were not made out 
with a  particular  objective  of  combination of  diabetes  and pulmonary 
tuberculosis.
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Gender Distribution
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2. AGE GROUP AND SEX BREAK UP OF   TB-DM CASES.
                                     
[N=56]
Table 1A
Age Group In 
years Male Female Total
<=20 0 0% 0 0% 0
21-30 0 0% 0 0% 0
31-40 6 17% 3 14% 9
41-50 14 40% 4 19% 18
51-60 7 20% 11 52% 18
61-70 6 17% 3 14% 9
>70 2 6% 0 0% 2
Total 35 100% 21 100% 56
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Age and Gender Distribution
0% 0%
17%
40%
20%
17%
6%
0% 0%
14%
52%
14%
0%
  19%
0%
10%
20%
30%
40%
50%
60%
 <=20 21-30 31-40 41-50 51-60 61-70 >70
Male
Female
Chi-Square Tests
7.407 4 .116
56
Pearson Chi-Square
N of Valid Cases
Value df P-value
INFERENCE
In the DM -TB group of 56 patients majority were above 40 years of age 
                   
i) In below 20 years group   0 cases were 
seen
ii) In 21 to 30 years group 0 cases were seen 
iii)  Above 40 years of age,             47 cases were   found. 
iv) In   41 -50 years group,            14 cases were present
v) In 51 to 60 years age group,      18 cases were found. 
vi) In 61 - 70 years age group,          9 cases  were found  
vii) Maximum cases were found between 41 to 50 years
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Age and Gender Distribution
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35%
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45%
 <=20 21-30 31-40 41-50 51-60 61-70 >70
Male
Female
viii) 45 cases were found between   31 to 60 years of age
3.  AGE WISE BREAK UP OF 
NON DM-TB  GROUP
TABLE -1 B
Age Group In 
years Male Female Total
<=20 2 5% 1 8% 3
21-30 4 9% 5 38% 9
31-40 9 21% 2 15% 11
41-50 13 30% 2 15% 15
51-60 10 23% 2 15% 12
61-70 3 7% 1 8% 4
>70 2 5% 0 0% 2
Total 43 100% 13 100% 56
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Chi-Square Tests
7.332 6 .291
56
Pearson Chi-Square
N of Valid Cases
Value df P-value
Chi-Square Tests
2.703 1 .100
112
Pearson Chi-Square
N of Valid Cases
Value df P-value
INFERENCE 
In the NON DM-TB group,                                 
i) In  the  NON  DM  -TB  group   of  56   patients 
majority were above 30  years of age 
ii) In below 20  years group  3 cases were seen
iii) In 21  to 30 years  group, 4   cases were seen 
iv) Above 40 years of age,  33 cases were   found 
v) In   41 -50  years group,15 cases were present
vi) In 51 to 60  years  age , there were 18 cases     
vii) In 61 - 70 years age group , there were 9  cases  
viii) Maximum cases were  between  41 to 50  years
ix) 38 cases were found between    31 to 60 years 
x) Other  groups  show  a  more  uniform  pattern  of 
distribution.
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INFERENCE 
i. Maximum patients were found in 31 to 40 years and 41 to 50 
years age group.
ii. Presence of  cases distributed among all  age  groups in  NON 
DM-TB   group is a differentiating picture in the study. 
4. SYMPTOMATOLOGY:
In terms of symptomatology the subjects suffering from tuberculosis 
alone and with diabetes and pulmonary tuberculosis were considered, the 
break up of symptoms presented in the table.
TABLE DEPICTING  SYMPTOMWISE  BREAK UP OF CASES
TABLE - 4A
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The DM-TB group was analysed for spectrum of symptoms and majority of 
the patients presented with 
1. Cough with expectoration 100 %
2. Haemoptysis                      32.1% 
3. Fever                                  53.6%
4. Chest pain                           5.45%
5. Loss of weight & appetite  23.2%
6. breathlessness                    39.3%
7. others                                 0%   
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INFERENCE 
The NON DM –TB   group was analyzed for the symptomatology and 
majority of the patients presented with,
                             1. fever                                        72%
                             2. breathlessness                         62.5%
      
Clinical symptoms were seen to be almost similar in both DM-TB and 
NON DM-TB group.  There  was  no  significant  difference  in  the  overall 
symptomatology.
1. This was similar to a study conducted in Regional Institute of Medical 
sciences,  Imphal  [2,  the  prevalence  of  TB  in  diabetics  was  27%  by 
radiological diagnosis  and  6% by sputum positivity. But the clinical 
symptoms and presentation of pulmonary tuberculosis was found to be 
similar in patients with or without diabetes.
Ref:     Indian. J. of Med Res., 130 July 2009, pp   1-4.
2. Also  similar  study  in  Pakistan  in  2006,  shows  similar  findings  with 
regards to symptomatology. “ Though the presenting symptoms of   PTB 
does not seem to modified with DM,  yet DM , can affect the radiological 
findings.
   Ref:    1. ANNALS vol. 15   NO.2 APR-JUN 2009 ,   QUAZI et al
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Smoking Vs Group
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The other two studies showing no significance between symptomatology in 
DM and NON DM-TB are          
              2. Kossii et al., Pulmonary tuberculosis in diabetics. Respiration.
              3. Perez Guzman C et al., Ind .J of Tub.  Lung Dis. Apr 2003.
6. SMOKING HABITS AMONG MALES
TABLE - 5
Smoking among 
Males
DM-TB GROUP NON DM-TB GROUP
No. % No. %
Yes 33 58.9% 31 55.4%
No 23 41.1% 25 44.6%
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Chi-Square Tests
.146 1 .703
112
Pearson Chi-Square
N of Valid Cases
Value df P-value
  
 
INFERENCE 
The prevalence of  smoking among TB in both DM and NON-DM 
were 58. % and 55.4%.
This shows that smokers are more prone to develop tuberculosis than non 
smokers. Though there was no statistical significant correlation between DM 
and  NON  DM-TB,  diabetes  adds  to  the  increased  susceptibility  for  TB 
among smokers than, non smokers and NON DM group.
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Sputum AFB across Groups
55.4%
44.6%
57.1%
42.9%
0.0%
10.0%
20.0%
30.0%
40.0%
50.0%
60.0%
Study Group Control
Sputum AFB positive
Sputum AFB negative
Chi-Square Tests
.036 1 .849
112
Pearson Chi-Square
N of Valid Cases
Value df P-value
7. TABLE  DEPICTING  OCCURRENCE  OF  SPUTUM  AFB 
POSITIVITY AMONG   TB-DM AND  NON DM-TB GROUP
                                   
TABLE – 6
Groups Sputum AFB positive
Sputum AFB 
negative
DM-TB group 55.4% 44.6%
NON DM-TB group 57.1% 42.9%
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Of the  5oo DM patients,  31  case    [55.4  %]  were  found  to  be  sputum 
positive for Acid Fast Bacilli. 
In NON DM –TB group 25 case [44.6%] were found to sputum positive.
The P value was 0.849 [p>0.05] and hence there was no statistical 
significance of   difference of sputum positivity between the two groups. 
Hence  both  diabetics  and  non  diabetic  TB  group  showed  similar 
sputum positivity  rates,  although  it  was  slightly  higher  in  the  DM –TB 
group, this may be attributed to the more severe type of presentation in DM, 
increased  mortality  patterns  in  DM    and    also    to  delayed  sputum 
conversion rates.
1. This matches a study in Nijmegen,  with higher sputum positivity and 
persistence after treatment owing to the initial higher bacterial load.
 
8. TYPE  OF  VARIOUS  RADIOLOGICAL  LESIONS  AND  THE 
PATTERN  OF  DISTRIBUTION  OF  SUBJECTS    WITH 
DIABETES AND  PT    [ DM-TB]
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[N=56]
    
TABLE-8A
Type of lesion
Bilatera
l
Right Left
Bilatera
l
Right Left
Infiltration 22 19 4 49% 42% 9%
Pleural effusion 0 0 0 0% 0% 0%
Fibrosis 1 1 1 33% 33% 33%
Cavity with 
infiltration
2 3 3 25% 38% 38%
Consolidation 0 0 1 0% 0% 100%
Bronchiectasis 2 0 0 100% 0% 0%
Infiltration & 
Cavity with 
infiltration & 
Fibrosis
0 0 0 0% 0% 0%
TOTAL 48.2% 16.07% 41.07%
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INFERENCE 
In the DM TB GROUP, n=56  the types of lesions were  
                1. Infiltration              in        35  patients   
                2. pleural effusion      in          0 patients
                3.  fibrosis                    in          3  patients
                4. consolidation           in         1 patient
                5. bronchiectasis         in         2 patients                    
                6. infiltration with cavity     in 8  patients
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There were more bilateral involvement in the   infiltration pattern of 
lesions and bronchiectasis. Left sided lesions were more with consolidation, 
cavity with infiltration and fibrosis.  
This is in similarity with various studies  like,
   1. “Tuberculosis  had more pronounced radiological signs.” 
Lalit Kant., Ind. J . of  Tub., No.4., Vol .50 .,New Delhi.,Oct.2003
   2.   Mboussa et al., Course of TB.,Rev Pneumol clinic .2003.
8B.    TYPE OF VARIOUS RADIOLOGICAL LESIONS AND THE 
           PATTERN OF DISTRIBUTION AMONG NON DAIBETIC TB 
           POPULATION [ NON DM-TB ]
          [ N=56 ]
TABLE  8 B
Type of lesion Bilateral Right Left
Bilatera
l Right Left
Infiltration 8 28 1 22% 76% 3%
Pleural effusion 0 0 0 0% 0% 0%
Fibrosis 0 0 0 0% 0% 0%
Cavity with 
infiltration
0 7 8 0% 47% 53%
Consolidation 0 0 1 0% 0% 100%
Bronchiectasis 0 1 0 0% 100% 0%
Infiltration & Cavity 
with infiltration & 
Fibrosis
0 0 0 0% 0% 0%
14.2% 64.28% 17.85%
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INFERENCE 
In the NON DM –TB group   the following pattern of distribution of 
radiological lesions were seen.
                   
                   1. infiltration    was seen in                     42 patients
 
                   2. consolidation was seen  in                  one patient 
                   3. bronchiectasis was seen in                  one patient
                   4. Infiltration with cavity was seen in    15 patients. 
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The study shows a more right sided pattern of infiltration in NON DM 
–TB Group. Also right sided lesions were seen as equally as left sided lesion 
in cavity with infiltration type of lesions. 
On comparing between the pattern of distribution among DM-TB and 
NON  DM-TB  group,  there  was  significant  frequency  of  more  bilateral 
lesions in 
TB-DM group.
Also cavity with infiltration were seen bilaterally only DM-TB group. 
No cases of  bilateral  cavity  with infiltration was seen in  NON DM-TB 
group. 
  This  is  in similarity with  the  other studies  like 
1. Quazi et al  study conducted during 2006, where “bilateral lesions were 
found   in  27%  of DM-TB”. 
2. Ind. J .Med .res.,  July 2009.,Young et al., “ concomitant TB and DM is 
associated  with  more  severe  features  including  increased  lung 
cavitations.”
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9. NO .OF ZONES  INVOLV ED  IN DM-TB GROUP AND 
     NON DM - TB GROUP
TABLE 9
 NO.OF 
ZONES Cases Control Cases Control
ONE 14 40 26% 74%
TWO 28 34 45% 55%
THREE 6 8 43% 57%
FOUR 2 0 100% 0%
FIVE 1 0 100% 0%
SIX 0 0 0% 0%
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INFERENCE 
There were more number of zones involved in each case of DM-TB 
than 
 
NON DM-TB.
1. Three  zone  involvement  was  seen  in  almost  similarity  in  both  the 
groups.
2. Four zone involvement was seen only in  DM-TB group.
3. Five zones involvement is seen only in DM-TB group.
This was seen in other related studies like
1. Perz Guzman et al .,Mexico.,2002., 
2. Shaik M.A.et al.,  Saudi Arabia.,  1994., “48% had lower lung zones 
involved”
3. F.A. Deshmukh ., et al., Bihar 1984.
4. Quazi  et  al.,  2006   Pakistan.,  “  in  75  x  ray  films  22  cases  showed 
multiple shadows  and atypical radiological involvement  with   13% 
middle zone involved   and  58% lower zone   involved .”
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                                                CONCLUSIONS
The following are  the conclusions drawn from the  above study of 
Patients with study of patients with diabetes and pulmonary tuberculosis.
 
  1.     The prevalence of pulmonary tuberculosis in diabetics is 11.2   
     
           percent.
2.   The female and male sex ratio of pulmonary tuberculosis in 
        diabetics is
                   M : F   =    1.67     for study      group       & 
                 
                   M:F     =    3.31    for  control   group.
3.   Age group distribution of patients suffering from PT and diabetes 
 
       show a majority  (  82.1% ) belonging to more than  40 years 
       of age control group 62.5%.
       In comparison, the control group show a more or less uniform 
       distribution of patients in age groups between 30 to 70 years.
        Even then there was no 
      
                 stastical correlation to suggest that diabetes produces more TB 
 
                 lesions in the elderly population.      (P  = 0.29 )
         4.     Majority of patients in Study group presented with fever  
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                 (53.65  %), 
                  chest pain  (    5.42%  ),   loss of appetite  (  23.2   %) , 
                  weight  loss (  23.2   %),   and  Haemoptysis  (   32.1%) . 
                  In the  control   group     (75%)    had   fever,  0 %   had 
                 chest pain , loss of appetite was seen  in    30.4%   . Weight loss in 
                  21.4% ,and    Haemoptysis in  7.1%    .    
                                              The   symptom   complex    as   per the study 
   
                  in both group  ,  was found to be similar and there is no stastical 
                  correlation between presence or absence of diabetes influencing 
                  the complaints of the  patients .
5. There increased susceptibility of tuberculosis in diabetic 
smokers than non smokers 
            
                 6.Study group:
                      Radiological studies showed that 48..21%   had bilateral  
                      lesions  .  16.07%    left sided  and    41.07 %  right sided 
                     lesions.
                   Control group:
                      Bilateral       14.2%
                      Right sided    64.28%
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                      Left sided     17.85%
               7.    In   study group sputum  positive  were  55.4%
                      In   control group sputum positive were   44.6%
 
                8.  In the   study   group  58.9% were smokers  and in
                                 control group   41.1% were smokers.
               9.    in the study group  three zones were involved in 10.7%
                                                     four zones involved in      3.57%
                                                     five  zones were involved in 1.78 %
  
                     whereas in control group it was   three zones  14.2%
                                                                          four   zones    0%
                                                                          five zones       0 %   
                   This shows more number zones involved bilaterally in diabetics 
                   than controls.
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